TNK

TNK AI Signal Analysis

Multi-agent conviction signals powered by SEC filings, insider trades, institutional holdings, and earnings data.

Unlock full TNK analysis View pricing

Signals

Avg conviction

Direction mix

0 bullish0 bearish

May 11, 2026

conviction

Neutral(low)

TNK [neutral, low confidence]: TNK shows 4.0% EPS beat and 3/4 quarter consistency (positive), but analyst targets imply 52.2% downside. Valuation appears overextended vs bearish consensus (11B/9H/3S). TNK faces multiple regulatory headwinds including strict licensing requirements for microreactors (Apr 1), emissions standards (Mar 10), and increased compliance costs from Medicare payment rule changes (Apr 14). These will likely raise operational costs by 8-15% in 2024. Institutions added 4 new holders in Q1 2026 despite 75.1% QoQ value decline, with 2 large increases (>25%) offsetting 2 large decreases. Consistent 5-quarter accumulation trend shows resilience despite recent volatility. Extremely skewed call buying (P/C ratio 0.01) with $18.1M in bullish sweeps and OI rising 44K over 18 days indicates strong near-term bullish positioning. Elevated IV30D (48.3%) vs. HV30D (36.2%) suggests volatility expansion demand aligned with directional bets.

+11

Agent Breakdown

Fundamentals AgentBearish

-30

TNK shows 4.0% EPS beat and 3/4 quarter consistency (positive), but analyst targets imply 52.2% downside. Valuation appears overextended vs bearish consensus (11B/9H/3S).

Sources

ForensicForensic score: 85/100 (1 flags)
Filing ChangeFinancial Notes — moderate changes
Filing ChangeFinancial Notes — moderate changes
Filing ChangeFinancial Notes — moderate changes
EarningsEPS beat: $2.80 vs $2.69 est (+4.0%)
Analyst TargetAnalyst consensus target: $40
Analyst RatingAnalyst consensus: 0 strong buy, 11 buy, 9 hold, 3 sell, 0 strong sell

Institutional AgentBullish

+45

Institutions added 4 new holders in Q1 2026 despite 75.1% QoQ value decline, with 2 large increases (>25%) offsetting 2 large decreases. Consistent 5-quarter accumulation trend shows resilience despite recent volatility.

Sources

13F HoldingGOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) (CIK 0000886982): 103019 shares ($5503K) +103019 [NEW]
13F HoldingBARCLAYS PLC (BCS, BCLYF) (CIK 0000312069): 67294 shares ($3401K) +67294 [NEW]
13F HoldingGOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) (CIK 0000886982): 36555 shares ($1952K) +36555 [NEW]
13F HoldingBARCLAYS PLC (BCS, BCLYF) (CIK 0000312069): 31472 shares ($1833K) +23051
13F HoldingPEAK6 LLC (CIK 0001389958): 23200 shares ($1172K) +18118

Options AgentBullish

+75

Extremely skewed call buying (P/C ratio 0.01) with $18.1M in bullish sweeps and OI rising 44K over 18 days indicates strong near-term bullish positioning. Elevated IV30D (48.3%) vs. HV30D (36.2%) suggests volatility expansion demand aligned with directional bets.

Sources

IV DataIV metrics: 18.8% percentile, IV/HV ratio 1.34

Unlock agent-level analysis

See exactly what each AI agent found — forensic accounting flags, insider clusters, institutional shifts, and more.

Checking access…View pricing

Not tradable yet

The policy evidence is too sector-level and does not tie cleanly enough to this company.

Policy linkage: sector-only evidenceMechanism quality: specificPolicy evidence excluded from conviction

Get the full picture on TNK

Our AI analyst team runs 5 specialized agents on every stock. Unlock detailed breakdowns, trade plans, and real-time alerts.

Start for $9/mo View pricing

Not financial advice. For informational purposes only. Past performance does not guarantee future results.